At this time, New York Oncology Hematology does not have access to acquire and administer the new COVID prophylaxis shot Evusheld for immunocompromised patients. We await further guidance from NYS and will keep our patients updated.

About Us

Dr. Bellomo Discusses CAR T-cell Therapy in HemOnc Today

6/15/2020

NYOH's Dr. Courtney Bellomo is featured on the cover of the June issue of HemOnc Today. Inside the medical journal, she offers her perspective on the quality of life challenges still facing patients receiving CAR T-cell therapy. CAR T-cell therapy is a new treatment, where a patient's cells are removed, genetically modified in a lab and returned to the body to fight cancer. Dr. Bellomo was selected as a "Next Gen Innovator" by HemOnc Today and is tapped to provide opinions on new research and important issues in hematology.